- Safety data analysis and reporting in clinical trials of the COVID jabs appear to have been manipulated in at least some cases. One method for manipulating randomized clinical trial safety data is to only analyze the “per protocol” treatment group (those who completed all doses and were fully compliant with the study design) as opposed to “intent to treat” which would include all patients that have signed informed consent
- For example, if a participant only accepted one dose and trial protocol called for two, under a “per protocol” analysis, adverse events they experienced would be dismissed and not included in the safety analysis. This is a classic way to manipulate safety data in clinical research, and it’s usually forbidden
- Since the COVID shots only have emergency use authorization, they are experimental products and, as such, they are not authorized for marketing
- Bioethics are written into federal law. As an experimental trial participant, you have the right to receive full disclosure of any adverse event risks. Full disclosure of risks is not being done, and in fact is being suppressed
- Adverse event risks must also be communicated in a way that you can comprehend what the risks are, and the acceptance of an experimental product must be fully voluntary and uncoerced. Enticement is strictly forbidden
As the inventor of the messenger RNA (mRNA) vaccine platform, Dr. Robert Malone is one of the most qualified individuals to opine on the benefits and potential risks of this technology.
His background includes a medical degree from Northwestern University, a master’s degree from Salk Institute, a bachelor’s degree in biochemistry from UC Davis, a Giannini fellowship in pathology and a post-graduate fellowship in global clinical research at Harvard.
He taught pathology to medical students for about a decade at the University of Maryland and the University of California Davis, and then became an associate professor of surgery at Uniformed Services, University of the Health Sciences, where he launched a major research institute focused on breast cancer and high-throughput screening in genomics for breast cancer.
After that, he helped found a company called Inovio, which has brought forth a number of gene therapy discoveries, including vaccines, and the use of pulsed electrical fields as a delivery method. After 9/11, a colleague at the University of Maryland’s department of business and economic development connected him with Dynport Vaccine Company, a startup that had received a DoD contract to manage its biodefense products.
“That’s when I transitioned from being more of an academic to the advanced development world of clinical research, regulatory affairs, project management, compliance, quality assurance — all of that stuff that goes into actually making a product,” Malone explains.
“It was a huge epiphany that the world really didn’t need more academic thought leaders and [that] I was wasting my time focusing on that. What the world really needed was that people understood the underlying technology and the discovery research world, but also understood advanced development, which is that drug development is a highly-regulated world. And there aren’t very many of those.
So, I set out to become really expert in that latter part and worked with the government, particularly in biodefense and vaccine development, for a couple of decades. And that brings me to the present.
I’ve captured a couple of billion dollars in grants and contracts for companies that I’ve worked with, and clients from the government, from BARDA [Biomedical Advanced Research and Development Authority], from the Department of Defense and others.”
COVID-19 ‘Vaccines’ Are Gene Therapy
I’ve been accused of falsely stating that these COVID shots are not vaccines but gene modifying interventions. However, even Malone agrees with this statement, and as the inventor of the technology, he should know. He points out that in Germany, by law you cannot refer to this technology as a genetic vaccine or gene therapy vaccine. “The German government has specifically outlawed the use of gene therapy-based vaccine as a term,” he says.
With his background, and having received the COVID shot himself, he can hardly be called an “anti-vaxxer” and/or someone who doesn’t believe in gene therapies. Yet, he recently went public with concerns about the safety of rolling out this kind of technology on a mass scale, and the unethical ways in which they’re being promoted.
As has become the trend, he was immediately censored. Wikileaks even went so far as to erase him from the historical section of the mRNA vaccine page and his own personal Wikipedia page was removed. All references to Malone inventing the mRNA technology were removed and attributed to a variety of institutions instead.
Blowing the Whistle
Malone’s public involvement with the COVID jab issue began with a short essay1 reflecting on the bioethics of the current campaign to get a needle in every arm. This essay grew out of a conversation he’d had with a Canadian physician. Malone’s essay catalyzed an interview with Bret Weinstein in June 2021 on the DarkHorse Podcast.
This isn’t the first time Malone has spoken out against unethical behavior in science. He was also a whistleblower in the Jesse Gelsinger death case,2 back in 1999. Gelsinger was a young man who had a rare metabolic disorder called ornithine transcarbamylase deficiency syndrome (OTCD), where dangerous amounts of ammonia build up in your blood.
He’d been diagnosed at the age of 2, and was managing his condition with a regimen of nearly 50 drugs a day. At 17, Gelsinger signed up for an investigational gene therapy. Like the COVID shots, the therapy involved injecting a gene attached to an adenovirus, which would be integrated into his DNA to permanently produce an enzyme that prevents ammonia buildup.
Gelsinger was the 18th person to receive the gene therapy, and while the others had only experienced mild side effects, Gelsinger had a severe response after scientists at the University of Pennsylvania administered adenoviruses doses that were far above what had been approved by the corresponding safety committee.
Gelsinger became disoriented and developed jaundice and acute inflammation, followed by a rare blood clotting disorder and multi-organ failure. He was dead within days. Even a decade later, Gelsinger’s death is still considered the biggest setback for gene therapy.3
“When the Jesse Gelsinger events happened, I also had long been a deep insider in the gene therapy space, so I had specific knowledge of what had happened at Penn — the ethical transgressions, shall we say, that occurred — and had awareness, again, just like now, of the technology,” Malone says. “So, I was able to make sense of things that otherwise were obscure for journalists and even other scientists.”
After speaking out about the ethical transgressions that contributed to Gelsinger’s death (dosing which exceeded approved levels), Malone became a “persona non-grata” in the gene therapy community. In other words, he was blacklisted by his peers and prevented from participating in gene therapy research.
“That’s part of why I went in a different direction with my career and focused on government work and biodefense, supporting the Department of Defense,” Malone says. “The lesson learned for me is that I’m able to be resilient, together with my wife’s support.
Another key lesson was that your friends will support you through times of crisis if you behave with integrity and maintain your friendships and treat people with respect. I also had a lot of support for having spoken out and taken an ethical high road on that and not compromised myself …
It’s part of why I’m comfortable [speaking out now]. People tell me that I come across as balanced and calm. But yes, this is a little bit frightening and once again, [I’m] putting my career on the line. But once again many of my colleagues in the government are grateful that I’m speaking this way. They are not able to have a voice because of their jobs and government policies about speaking out.”
Public Responses to Censorship Make a Difference
As explained by Malone, he’s been heavily censored since his three-hour interview with Brett Weinstein. LinkedIn even deleted his account. However, LinkedIn users all around the world canceled their accounts in protest and wrote the company, explaining their cancellations were in protest of Malone being censored.
The social media uproar culminated in a major news article in a mainstream Italian paper, which appears to have pushed LinkedIn over the edge. LinkedIn eventually reinstated Malone’s account and even sent him a letter of apology.
“I don’t think I’ve ever heard of a company writing a letter of apology after delisting and deleting somebody,” he says. “My sins were ‘profound,’” he says sarcastically, “They were that I outed the chairman of the board of directors of Reuters who is also sitting on the board of Pfizer, for cross-posting the Wall Street Journal article on vaccine toxicity risks, and well, basically for complaining about censorship.
So, they sent me my list of sins with six different posts that were to pretty much anybody’s eye innocuous, which I then took and cross-posted onto Twitter. So, that revealed the absurdity of that … The note [of apology] that I received basically said, ‘Look, we don’t have the expertise to censor you, but if you cross the line, we have the right to summarily delete you again and so mind your manners.’”
The Repurposing of Drugs to Combat Pandemics
In recent years, Malone has been involved in yet another startup company (Atheric Pharmaceuticals), in collaboration with the DoD, that focused on repurposing drugs to combat Zika infection. That company went bankrupt for lack of investor interest in repurposing drugs for treating infectious diseases.
When the COVID-19 outbreak began, he got a call from a colleague who works in the intelligence community in Wuhan, China, who urged him to put together a team to investigate the possibility of repurposing old drugs against COVID.
His team is currently about to enter clinical trials for a number of licensed off-patent drugs. That said, his biggest contribution so far is probably his commentary on the bioethics of what is going on.
“Both my wife and I are deeply ethical people,” he says. “We’re high school sweethearts. We try really hard to live ethical lives and to help our fellow man as well as the animals in our lives. So that’s just the place we come from. It’s bedrock. We’re not rich people.
I recall a long telephone call with the Canadian physician that poured his heart out about the situation in Canada that he’s encountering, both with vaccine administration in primary practice, and also in administering alternative therapies to outpatients, which generally have no therapies available.
I mean, the position is a bit shocking — in the emergency rooms all across the world. Basically, you go to the ER and if your O2 sets are down, pushing towards 80, they say, ‘Well, go [home] and come back when your lips are blue.’ And that’s the essence of it. They don’t really offer anything.
So many physicians, including this gentleman in Canada, have been seeking alternative strategies and they’ve tested and administered these various agents. We’ve heard of fluvoxamine, ivermectin, hydroxychloroquine. There are many, many others now, including those that we’re working with (famotidine and celecoxib) that seem to have therapeutic benefit when administered early to shut down this hyperinflammatory response.